Christopher J. Langmead
Discovery Institute(US)Discovery Centre(CA)Australian Regenerative Medicine Institute(AU)Monash Medical Centre(AU)Phelix Therapeutics (United States)(US)Monash University(AU)Monash Institute of Medical Research(AU)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Nicotinic Acetylcholine Receptors Study
Most-Cited Works
- → Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation(2011)874 cited
- → Muscarinic acetylcholine receptors as CNS drug targets(2007)417 cited
- → Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design(2012)302 cited
- → International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands(2014)236 cited
- → Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists(2020)212 cited
- → The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery(2010)158 cited